stockrow
Friday 6 November 2026
Export BDMD’s income statement to Excel — free account
Baird Medical Investment Holdings Limited
BDMD Healthcare Medical Devices
0.09
0.07
−43.75%
Follow BDMD
Alert me
Target Price Range
Analyst price targets
Free accountTen years at a glance
| Ten-year view | Analyst estimates Powerpack | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend | 10 yrs | 2026e | 2027e | 2028e | Next 3/yr |
| Income, $m | |||||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Gross margin, % | — | — | — | — | — | — | — | — | — | — | — | ||||||
| EBT | — | — | — | — | — | (1) | 1 | — | — | — | n/m | ||||||
| EBT margin, % | — | — | — | — | — | 0.00 | 0.00 | — | — | — | 0.0 pt | ||||||
| Net income | — | 0 | — | — | — | (1) | 1 | — | — | — | n/m | ||||||
| Per share, $ | |||||||||||||||||
| Per share, $ | Revenue | — | — | — | — | — | 0.00 | 0.00 | — | — | 0.00 | n/m | |||||
| Earnings | — | — | — | — | — | (0.02) | 0.02 | — | — | (0.98) | +164.6% | ||||||
| Cash flow | — | — | — | — | — | (0.04) | (0.02) | — | — | 0.00 | n/m | ||||||
| Capex | — | — | — | — | — | 0.00 | 0.00 | — | — | 0.00 | n/m | ||||||
| Free cash flow | — | — | — | — | — | (0.04) | (0.02) | — | — | 0.00 | n/m | ||||||
| Book value | — | — | — | — | — | 7.91 | 0.00 | — | — | 0.00 | n/m | ||||||
| Shares, m | — | — | — | — | — | 29 | 29 | — | — | 28 | (0.8%) | ||||||
| Valuation, × | |||||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | — | — | — | — | |||||
| P/S | — | — | — | — | — | — | — | — | — | — | — | ||||||
| P/B | — | — | — | — | — | — | — | — | — | — | — | ||||||
| EV/Sales | — | — | — | — | — | — | — | — | — | — | — | ||||||
| EV/FCF | — | — | — | — | — | — | — | — | — | — | — | ||||||
| Cash, $m | |||||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | (1) | (1) | — | — | — | (44.6%) | |||||
| Capex | — | — | — | — | — | — | — | — | — | — | — | ||||||
| Free cash flow | — | — | — | — | — | (1) | (1) | — | — | — | (44.6%) | ||||||
| Balance, $m | |||||||||||||||||
| Balance, $m | Working capital | — | — | — | — | — | 0 | (2) | — | — | — | n/m | |||||
| Net debt | — | — | — | — | — | (1) | 0 | — | — | — | (91.4%) | ||||||
| Shareholders’ equity | — | — | — | — | — | 227 | — | — | — | — | — | ||||||
| Returns, % | |||||||||||||||||
| Returns, % | ROA | — | — | — | — | — | (0.59) | 0.26 | — | — | (22.87) | (22.3) pt | |||||
| ROIC | — | — | — | — | — | 0.00 | 0.00 | — | — | — | 0.0 pt | ||||||
| ROE | — | — | — | — | — | 0.00 | 0.27 | — | — | 0.00 | 0.0 pt | ||||||
| People | |||||||||||||||||
| People | Employees | — | — | — | — | — | — | — | — | — | — | — | |||||
| Revenue/emp, $m | — | — | — | — | — | — | — | — | — | — | — | ||||||
Negative figures in brackets.
estimates
Fundamentals updated 26 Oct 2026
Baird Medical Investment Holdings Limited vs peers in Medical Devices (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| INBS Intelligent Bio Solutions Inc. | $5.8M | — (loss-making) | — (loss-making) | +51.10% (above 0%: growing) | n/m | −31.59% (below 0%: shrinking) | 43.23% | (360.19%) | Compare |
| TBIO Telesis Bio Inc. | $5.3M | — (loss-making) | — (loss-making) | −71.85% (below 0%: shrinking) | n/m | −17.96% (below 0%: shrinking) | 64.43% | (349.74%) | Compare |
| VNRX VolitionRX Limited | $5.3M | — (loss-making) | — (loss-making) | −1.97% (below 0%: shrinking) | n/m | +18.58% (above 0%: growing) | 100.00% | (1,042.39%) | Compare |
| BDMD Baird Medical Investment Holdings Limited | $5.0M | — (loss-making) | — | — | n/m | −598.12% (below 0%: shrinking) | — | — | |
| NVNO enVVeno Medical Corporation | $4.8M | — (loss-making) | — (loss-making) | +0.32% (above 0%: growing) | n/m | +27.64% (above 0%: growing) | 0.00% | 0.00% | Compare |
| TNON Tenon Medical, Inc. | $4.4M | — (loss-making) | — (loss-making) | +126.77% (above 0%: growing) | n/m | −21.78% (below 0%: shrinking) | 63.64% | (262.24%) | Compare |
| WOK WORK Medical Technology Group LTD | $4.1M | — | — | — | — | −948.94% (below 0%: shrinking) | — | — | Compare |
| TRIB Trinity Biotech PLC | $3.8M | — (loss-making) | — (loss-making) | +43.28% (above 0%: growing) | n/m | +75.24% (above 0%: growing) | 35.43% | (24.53%) | Compare |
| XAIR Beyond Air, Inc. | $3.6M | — (loss-making) | — (loss-making) | +0.45% (above 0%: growing) | n/m | −9.10% (below 0%: shrinking) | 12.73% | (373.98%) | Compare |
| Median of peers | $4.6M | — | — | +0.45% | — | −13.53% | 43.23% | (349.74%) |